Predictors of persistence and adherence to deutetrabenazine among patients with Huntington disease or tardive dyskinesia.

Daniel O Claassen Rajeev Ayyagari Viviana García-Horton Su Zhang Sam Leo

Published in: The mental health clinician (2023)

Identifying factors predictive of discontinuation and/or nonadherence to deutetrabenazine may facilitate the development of personalized support programs that seek to improve outcomes in patients with HD or TD.

Keyphrases

public health
glycemic control
type diabetes
metabolic syndrome
adipose tissue
weight loss